Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
2
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
2 competitors in Epilepsy
View Full LandscapeNo patent data available. Pre-approval drugs may not have Orange Book listings.
Zebinix
Zebinix is indicated as adjunctive therapy in adults, adolescents and children aged above 6 years, with partial-onset seizures with or without secondary generalisation.
View on EMAExalief
Exalief is indicated as adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation.
View on EMA